Back3D Global Biotech Overview

3D Global Biotech Current Assets

3D Global Biotech's current assets is $550M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$551.05M
↓ 35.28% YoYΔ $-300.43M vs prior year quarter

Peer trimmed avg / median

Loading

3D Global Biotech Current Assets History

Loading

3D Global Biotech vs. peers: Current Assets Comparison

Loading

3D Global Biotech Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

3D Global Biotech (6808.TWO) FAQ

As of the most recent data (June 2026), 6808.TWO shows a current assets of $550M. That compares with $850M in the prior-year period — down 35.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6808.TWO's current assets is now $550M (was $850M) — a 35.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether 3D Global Biotech is outperforming or lagging.

Tracking 6808.TWO's current assets over time shows whether 3D Global Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $550M That compares with $850M in the prior-year period — down 35.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has 3D Global Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $550M) with ownership activity and broader fundamentals.

3D Global Biotech's current assets is $550M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.